Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP440324.RArDeXvlpnAWFYnhOVD_IHwKqaMD7e3qpp1T_HtQDRVGs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP440324.RArDeXvlpnAWFYnhOVD_IHwKqaMD7e3qpp1T_HtQDRVGs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP440324.RArDeXvlpnAWFYnhOVD_IHwKqaMD7e3qpp1T_HtQDRVGs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP440324.RArDeXvlpnAWFYnhOVD_IHwKqaMD7e3qpp1T_HtQDRVGs130_provenance.
- NP440324.RArDeXvlpnAWFYnhOVD_IHwKqaMD7e3qpp1T_HtQDRVGs130_assertion description "[Nearly half of these tumors are nonhyperdiploid and mostly have immunoglobulin H (IgH) translocations that involve 5 recurrent chromosomal loci, including 11q13 (cyclin D1), 6p21 (cyclin D3), 4p16 (fibroblast growth factor receptor 3 [FGFR3] and multiple myeloma SET domain [MMSET]), 16q23 (c-maf), and 20q11 (mafB).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP440324.RArDeXvlpnAWFYnhOVD_IHwKqaMD7e3qpp1T_HtQDRVGs130_provenance.
- NP440324.RArDeXvlpnAWFYnhOVD_IHwKqaMD7e3qpp1T_HtQDRVGs130_assertion evidence source_evidence_literature NP440324.RArDeXvlpnAWFYnhOVD_IHwKqaMD7e3qpp1T_HtQDRVGs130_provenance.
- NP440324.RArDeXvlpnAWFYnhOVD_IHwKqaMD7e3qpp1T_HtQDRVGs130_assertion SIO_000772 15090448 NP440324.RArDeXvlpnAWFYnhOVD_IHwKqaMD7e3qpp1T_HtQDRVGs130_provenance.
- NP440324.RArDeXvlpnAWFYnhOVD_IHwKqaMD7e3qpp1T_HtQDRVGs130_assertion wasDerivedFrom befree-2016 NP440324.RArDeXvlpnAWFYnhOVD_IHwKqaMD7e3qpp1T_HtQDRVGs130_provenance.
- NP440324.RArDeXvlpnAWFYnhOVD_IHwKqaMD7e3qpp1T_HtQDRVGs130_assertion wasGeneratedBy ECO_0000203 NP440324.RArDeXvlpnAWFYnhOVD_IHwKqaMD7e3qpp1T_HtQDRVGs130_provenance.
- befree-2016 importedOn "2016-02-19" NP440324.RArDeXvlpnAWFYnhOVD_IHwKqaMD7e3qpp1T_HtQDRVGs130_provenance.